THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT02002325

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02002325
Other papers using this trial's data
  • Associations between fluid-attenuated inversion recovery vessel hyperintensities and Alberta stroke program early CT score and clinical outcomes in stroke patients with unknown time of onset: A sub-analysis from a randomized controlled trial International journal of stroke : official journal of the International Stroke Society, 2026-03 DOI, PubMed 40884089
  • Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy Stroke, 2021-01 DOI, PubMed 33297866
  • Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial Stroke, 2020-05 DOI, PubMed 32248771, PMC7185058 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02002325. Randomized; single masking; primary purpose treatment. Start 2014-05 (actual); primary completion 2019-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
Acronym
THAWS
Condition
Stroke
Intervention (Drug)
Tissue-type plasminogen activator (alteplase)
Intervention (Other)
Standard care
Lead sponsor
National Cerebral and Cardiovascular Center, Japan (class: other)
Collaborator
Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund (class: not stated)
Collaborator
Japan Agency for Medical Research and Development (class: other government)

Record details

Record id
cardio:ct-nct02002325
Content hash
e7e17ef89a9c279a5753a6421bf7105662482d13e8648ec067094df29b6bcae9